Nevertheless, LCL-DOX inhibited statistically significant (by 40–60%) the expression of proteins involved in the anti-tumor response: TIMP-1, TIMP-2, IFN-γ, MIG, PF-4, and IL-12p70 (Figure 3 and Table 1). The gene discussed is TIMP2; the disease is neoplasm.